![Jian Irish](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jian Irish
Directeur Général chez
METAGENOMI THERAPEUTICS, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Jian Irish is currently Chief Executive Officer & Director at Metagenomi Therapeutics, Inc. since 2025.
Former positions include Chief Operating Officer at Metagenomi Technologies LLC in 2021, Chief Operating Officer at Affini-T Therapeutics, Inc. from 2021 to 2022, Chief Technology Officer & Director at Fosun Kite Biotechnology Co., Ltd. from 2018 to 2020, Senior Vice President & Global Head-Manufacturing at Kite Pharma, Inc. from 2016 to 2020, Vice President-Biologics Supply & Partnerships at Sanofi from 2015 to 2016, and Executive Director-Contract Manufacturing at Amgen, Inc. from 2000 to 2014.
Education includes graduate and doctorate degrees from Chiba University, an undergraduate degree from East China University of Science & Technology, and an MBA from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 962 960 ( 2,56 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Jian Irish
| Sociétés | Poste | Début |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Directeur Général | 11/11/2025 |
Anciens postes connus de Jian Irish
| Sociétés | Poste | Fin |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Directeur des opérations | 01/01/2022 |
| KITE PHARMA INC | Corporate Officer/Principal | 01/12/2020 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Directeur Technique/Scientifique/R&D | 01/04/2020 |
| SANOFI | Corporate Officer/Principal | 01/08/2016 |
| AMGEN INC. | Corporate Officer/Principal | 01/09/2014 |
Formation de Jian Irish
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Chiba University
 Chiba University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
 East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
